Universal screening at age 1-2 years as an adjunct to cascade testing for familial hypercholesterolaemia in the UK: A cost-utility analysis.
Atherosclerosis(2018)
摘要
These findings support implementation of universal cholesterol screening followed by diagnostic genetic testing and RCT for FH, under a UK conventional willingness-to-pay threshold.
更多查看译文
关键词
Hyperlipoproteinaemia type II,Systematic population screening,Cost-effectiveness
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络